Rubfila Intl. Q1 FY27 Results (NSE: RUBFILA)
Signal: Revenue declined
The read
The quarter shows a parent-level margin inflection but not a group-level recovery: standalone EBITDA rose 2.4% and PAT 0.7% despite revenue falling 10.7%, whereas consolidation reduced PAT to 580.00 lakh, -13.3% YoY, because the subsidiary remained loss-making and depreciation increased 7.2%.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹133.49 Cr | -7.9% | -16.9% |
| EBIT | ₹7.86 Cr | -12.2% | |
| Net profit | ₹5.8 Cr | -13.3% | |
| EPS | ₹1.07 | -13.0% | |
| EBIT margin | 8.1% |
P&L walk
Revenue declined to 13,348.98 lakh, -7.9% YoY and -16.9% QoQ, but EBITDA fell only 7.7% and margin improved to 8.1%; depreciation rose 7.2% and the subsidiary reported an 18.58 lakh loss, leaving PAT down 13.3% to 580.00 lakh.
Segments
The consolidated result is dragged by wholly owned subsidiary Premier Tissues India, which contributed 2,444.72 lakh of revenue but an 18.58 lakh net loss; standalone PAT was 599.70 lakh versus consolidated PAT of 580.00 lakh.
Key positives
- Standalone EBITDA increased 2.4% YoY to 1,040.00 lakh and standalone PAT increased 0.7% to 599.70 lakh despite revenue declining 10.7%, indicating improved parent-level cost absorption.
- Consolidated EBITDA margin was 8.1% on EBITDA of 1,075.00 lakh, while employee cost increased only 1.4% YoY to 1,104.75 lakh.
- Consolidated operating cash flow was positive at 864.88 lakh against PAT of 580.00 lakh, and cash and cash equivalents rose to 1,685.17 lakh.
Key concerns
- Consolidated revenue declined 7.9% YoY to 13,348.98 lakh, extending the slowdown from the prior quarter's 8.9% YoY growth to a sequential decline of 16.9%.
- The subsidiary generated 2,444.72 lakh of revenue but reported an 18.58 lakh net loss, causing consolidated PAT of 580.00 lakh to fall 13.3% despite standalone PAT rising 0.7%.
- Depreciation increased 7.2% YoY to 289.09 lakh while consolidated EBIT fell 12.2% to 786.00 lakh, limiting conversion of operating performance into profit.
Research and educational content only. Not investment advice.